Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP): A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315.

Griesinger, F., Eberhardt, W., Marschner, N., Jänicke, M., Hipper, A., Karatas, A., Sebastian, M., Thomas, M., Schirmacher, P., 2017.

J Thorac Oncol 12(1)(MA08.02), S385. doi:10.1016/j.jtho.2016.11.435

Studie: CRISP; Indikation: Bronchialkarzinom; Jahr: 2017; Veranstaltung: ELCC (IASLC); Journal: Journal of Thoracic Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com